Graham Capital Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,992
Closed -$299K 1132
2025
Q4
$299K Buy
29,992
+8,316
+38% +$79.4K 0.01% 856
2025
Q3
$194K Buy
+21,676
New +$201K ﹤0.01% 1059
2024
Q1
Sell
-98,311
Closed -$717K 1039
2023
Q4
$717K Buy
98,311
+69,169
+237% +$545K 0.02% 479
2023
Q3
$265K Buy
+29,142
New +$349K 0.01% 763
2022
Q2
Sell
-59,005
Closed -$945K 980
2022
Q1
$945K Buy
+59,005
New +$1.06M 0.03% 324

Other funds holding AHCO

Graham Capital Management's AHCO Position: Q1 2026 in Review

Graham Capital Management sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 29,992 shares — an estimated $299K sold.

Graham Capital Management first reported a position in AHCO in Q1 2022 and held it in 5 quarters. The position peaked at $945K in Q1 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Graham Capital Management reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 29,992 AdaptHealth shares in Q1 2026, an estimated $299K.
  • Graham Capital Management first reported a position in AdaptHealth in Q1 2022 and held it in 5 quarters.
  • Graham Capital Management's AdaptHealth position peaked at $945K in Q1 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.